The P3H1 gene osteogenesis imperfecta type 8 genetic test is a specialized diagnostic tool designed to identify mutations in the P3H1 gene, which are linked to osteogenesis imperfecta type 8 (OI type 8). Osteogenesis imperfecta, also known as brittle bone disease, is a group of genetic disorders that primarily affect the bones, leading to their increased fragility and susceptibility to fractures. Type 8 is a severe form of the condition, characterized by bone deformities, reduced bone mass, and other connective tissue symptoms.
This genetic test is crucial for the accurate diagnosis of OI type 8, enabling healthcare providers to tailor treatment plans and management strategies specific to the needs of the patient. Early diagnosis through genetic testing can significantly improve the quality of life for individuals with OI type 8 by implementing preventive measures against fractures, providing physical therapy, and other supportive care as needed.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the P3H1 gene osteogenesis imperfecta type 8 genetic test is 4400 AED. DNA Labs UAE employs state-of-the-art technology and follows stringent protocols to ensure the accuracy and reliability of the test results, providing patients and their families with crucial information for managing the condition.
The PPIB Gene Osteogenesis Imperfecta Type 9 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at detecting mutations in the PPIB gene, which are associated with Osteogenesis Imperfecta (OI) Type 9. Osteogenesis Imperfecta, also known as brittle bone disease, is a group of genetic disorders characterized by bones that break easily, often with little or no apparent cause. Type 9 OI is a rare form of this condition and is distinguished by specific genetic mutations in the PPIB gene, which is essential for the proper formation and maintenance of collagen in the bone structure.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for the presence of mutations in the PPIB gene. A positive result indicates a mutation in the PPIB gene, confirming a diagnosis of Osteogenesis Imperfecta Type 9. This information is crucial for the management and treatment of the condition, allowing for personalized care plans that can significantly improve the quality of life for affected individuals.
The cost of the PPIB Gene Osteogenesis Imperfecta Type 9 Genetic Test at DNA Labs UAE is 4400 AED. This cost covers the entire testing process, from sample collection to genetic analysis and reporting. The investment in this test can provide families with essential information regarding the genetic basis of OI Type 9, enabling informed decisions about care and treatment options. Given the complexity and rarity of Osteogenesis Imperfecta Type 9, accessing accurate and timely genetic testing like the one offered by DNA Labs UAE is a critical step in the journey towards understanding and managing this condition.
The "PLOD2 Gene Osteogenesis Imperfecta with Congenital Joint Contractures Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to detect mutations in the PLOD2 gene, which have been associated with a rare form of osteogenesis imperfecta (OI) characterized not only by brittle bones but also by congenital joint contractures. Osteogenesis imperfecta, commonly known as brittle bone disease, is a group of genetic disorders that primarily affect the bones, leading to fractures and bone deformities. The addition of congenital joint contractures, which are permanent shortenings of muscles or tendons around joints, causes further mobility and functional challenges for affected individuals.
The PLOD2 gene plays a crucial role in the biosynthesis of collagen, a key structural protein in bones and connective tissues. Mutations in this gene can disrupt collagen production, leading to the symptoms observed in this specific form of OI. The test offered by DNA Labs UAE involves analyzing the patient's DNA to identify mutations in the PLOD2 gene, providing crucial information for diagnosis, prognosis, and potential treatment strategies.
Priced at 4400 AED, this genetic test is a valuable resource for families seeking answers to unexplained bone fragility and joint issues present from birth. It aids in the accurate diagnosis of this rare condition, enabling healthcare providers to tailor management and intervention strategies to the specific needs of the patient, potentially improving their quality of life.
The TNFRSF11A gene plays a crucial role in the development and regulation of bones, as it is involved in the process of osteoclast differentiation, which is essential for bone remodeling. Mutations in the TNFRSF11A gene can lead to a rare genetic disorder known as familial expansile osteolysis (FEO), characterized by abnormal bone growth, bone pain, and hearing loss. The disorder is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
To diagnose this condition, a genetic test targeting the TNFRSF11A gene can be performed. This test involves analyzing the DNA to identify mutations in the TNFRSF11A gene that are responsible for the condition. It provides crucial information for the diagnosis, management, and genetic counseling of affected individuals and their families.
In the UAE, DNA Labs UAE offers this specific genetic test for familial expansile osteolysis. The cost of the test is set at 4400 AED. Conducting the test in a specialized facility like DNA Labs UAE ensures accuracy and reliability of the results, which are critical for the effective management of the condition and the well-being of the patient and their family.
The "IL1RN Gene Osteomyelitis Sterile Multifocal with Periostitis and Pustulosis Genetic Test" is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the IL1RN gene. These mutations are associated with a rare autoinflammatory condition characterized by sterile multifocal osteomyelitis, periostitis, and pustulosis. This condition often presents with bone pain, skin lesions, and systemic inflammation without the presence of infectious agents. The test is crucial for accurate diagnosis, guiding treatment strategies, and understanding the prognosis of affected individuals. Conducted through a sophisticated analysis of the patient's genetic material, this test helps in identifying the specific genetic anomaly responsible for the condition. The cost of the test is 4400 AED, reflecting the advanced technology and expertise required to perform this detailed genetic analysis. By opting for this test at DNA Labs UAE, patients and healthcare providers can gain valuable insights into the genetic basis of this rare disease, enabling targeted and effective management of the condition.
The IFNGR1 gene plays a crucial role in the immune response to mycobacterial infections. Mutations in this gene can lead to a condition known as Atypical Familial Disseminated Mycobacterial Infection, where affected individuals are more susceptible to infections caused by mycobacteria, including the bacteria responsible for tuberculosis and leprosy. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
To diagnose this condition and identify carriers of the mutation, a genetic test targeting the IFNGR1 gene can be performed. This test is crucial for families with a history of atypical mycobacterial infections, as it helps in understanding the genetic predisposition and in taking preventive measures for family members who may be at risk.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 4400 AED. The testing process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for mutations in the IFNGR1 gene. Results from this test can provide valuable information for affected individuals and their families regarding the management of the condition and the risk of passing it on to future generations.
The KRT14 Gene Naegeli-Franceschetti-Jadassohn (NFJ) Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the KRT14 gene, which are responsible for the rare genetic disorder known as Naegeli-Franceschetti-Jadassohn Syndrome. This condition is characterized by a range of dermatological manifestations including reticular skin pigmentation, palmoplantar keratoderma, and in some cases, dental anomalies and diminished sweating (hypohidrosis). The test plays a crucial role in confirming the diagnosis, allowing for appropriate management and genetic counseling for affected individuals and their families. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. By opting for this test at DNA Labs UAE, patients and healthcare providers can expect reliable and accurate genetic insights, paving the way for better understanding and management of Naegeli-Franceschetti-Jadassohn Syndrome.
The LMX1B Gene Nail-Patella Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the LMX1B gene, which are associated with Nail-Patella Syndrome (NPS). NPS is a rare genetic disorder characterized by abnormalities of the nails, kneecaps (patellae), elbows, and sometimes kidneys and eyes. The condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder.
This test is particularly crucial for individuals showing symptoms of NPS or those with a family history of the condition, as it can provide definitive confirmation of the diagnosis. Early diagnosis through genetic testing can aid in the management and treatment of the syndrome, potentially mitigating some of its effects on the joints, kidneys, and eyes.
The test is available at DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. The cost of the LMX1B Gene Nail-Patella Syndrome Genetic Test is 4400 AED. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the LMX1B gene. Results from this test can guide healthcare professionals in providing personalized care plans for affected individuals, including recommendations for monitoring and managing potential complications associated with NPS.
The SLC9A3R1 gene plays a crucial role in the body's ability to manage minerals and electrolytes, which are vital for bone health and kidney function. Mutations in this gene can lead to a rare condition known as Nephrolithiasis-osteoporosis, hypophosphatemic type 2, characterized by the development of kidney stones and decreased bone density due to an imbalance in phosphate levels. To diagnose this condition, a specific genetic test targeting the SLC9A3R1 gene mutations can be conducted. This test is essential for confirming the diagnosis, understanding the risk of passing the condition to offspring, and guiding treatment options.
At DNA Labs UAE, this specialized genetic test is available for individuals who may be at risk of this condition or are experiencing symptoms related to kidney stones and bone health issues. The test cost is set at 4400 AED, reflecting the comprehensive analysis and the detailed report provided by the lab. Conducting this test at DNA Labs UAE ensures accuracy and reliability, supported by their expertise in genetic diagnostics and counseling services to help patients understand their results and the implications for their health and family.
The SPINK5 Gene Netherton Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the SPINK5 gene, which are associated with Netherton Syndrome. Netherton Syndrome is a rare genetic condition characterized by skin abnormalities, hair shaft defects, and immune system issues. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic alterations in the SPINK5 gene, offering crucial information for accurate diagnosis and management of the syndrome. This test is an essential tool for families with a history of Netherton Syndrome, enabling early intervention and personalized care plans for affected individuals.
